Skip to main content
English
Català
Čeština
Deutsch
Español
Français
Gàidhlig
Italiano
Latviešu
Magyar
Nederlands
Polski
Português
Português do Brasil
Srpski (lat)
Suomi
Svenska
Türkçe
Tiếng Việt
Қазақ
বাংলা
हिंदी
Ελληνικά
Српски
Yкраї́нська
Log In
Email address
Password
Log in
Have you forgotten your password?
Communities & Collections
All Contents
Statistics
English
Català
Čeština
Deutsch
Español
Français
Gàidhlig
Italiano
Latviešu
Magyar
Nederlands
Polski
Português
Português do Brasil
Srpski (lat)
Suomi
Svenska
Türkçe
Tiếng Việt
Қазақ
বাংলা
हिंदी
Ελληνικά
Српски
Yкраї́нська
Log In
Email address
Password
Log in
Have you forgotten your password?
Home
Araştırma Çıktıları | Web Of Science
Web of Science Koleksiyonu
English
English
No Thumbnail Available
Date
Authors
Özel, Y
Cavus, I
Yilmaz, U
Tokay, F
Bagdat, S
Özbilgin, A
Ünlu, M
Ünlu, GV
Journal Title
Journal ISSN
Volume Title
Publisher
0374-9096
Abstract
ANKARA MICROBIOLOGY SOC
Description
Keywords
In recent years, isolation of resistant Leishmania species to drugs in use has made it necessary to search alternative molecules that may be drug candidates. In this study, it was aimed to investigate the cytotoxic and in vitro antileishmanial activity of hybrid silver nanoparticle (AgNP) complexes. In this study, three types of nanoparticles (NPs), oxidized amylose-silver (OA-Ag) NPs, oxidized amylose-curcumin (OA -Cur) NPs and oxidized amylose-curcumin-silver (OA-CurAgNP) nanoparticles were synthesized. The cytotoxic activity of the synthesized nanoparticles was determined against L929 mouse fibroblasts and the in vitro antileishmanial activity was determined against Leishmania tropica , Leishmania infantum and Leishmania donovani isolates by the broth microdilution method. It was observed that the hybrid OA-CurAgNP com - plex obtained by combining curcumin and silver nanoparticles showed cytotoxic effects against L929 mouse fibroblasts at concentrations of 1074 pg/mL and above. IC 50 values expressing the antileishmanial activity of the hybrid OA-CurAgNP complex against L.tropica , L.infantum and L.donovani isolates, were found to vary between 95-121 pg/mL, 202-330 pg/mL and 210-254 pg/mL, respectively. Resistance development has emerged as a major challenge in the treatment of leishmaniasis in recent times. Metallic nanoparticles are considered excellent candidates for medical applications due to their chemical and physical properties, as well as their prolonged circulation in the body. The current drugs used for leishmaniasis treatment are highly toxic, while nanoparticles offer advantages such as low toxicity and easy cellular uptake due to their nanoscale dimensions. The identification of strong efficacy in these particles may con - tribute scientific evidence for their potential use in leishmaniasis treatment. Therefore, the therapeutical value of OA-CurAgNP complex alone in combination with existing drugs should be examined.
Citation
URI
http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/7342
Collections
Web of Science Koleksiyonu
Full item page